Raymond James & Associates’s Charles & Colvard Ltd CTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,161
Closed -$27K 4132
2020
Q4
$27K Hold
2,161
﹤0.01% 3670
2020
Q3
$18K Hold
2,161
﹤0.01% 3514
2020
Q2
$16K Sell
2,161
-1,300
-38% -$9.32K ﹤0.01% 3456
2020
Q1
$23K Hold
3,461
﹤0.01% 3391
2019
Q4
$49K Buy
3,461
+1,705
+97% +$24K ﹤0.01% 3553
2019
Q3
$29K Buy
+1,756
New +$25.5K ﹤0.01% 3516
2019
Q2
Sell
-1,125
Closed -$13K 3775
2019
Q1
$13K Sell
1,125
-925
-45% -$9.16K ﹤0.01% 3557
2018
Q4
$17K Sell
2,050
-1,170
-36% -$10.6K ﹤0.01% 3448
2018
Q3
$28K Buy
+3,220
New +$32.5K ﹤0.01% 3528

Other funds holding CTHR

Raymond James & Associates's CTHR Position: Q1 2021 in Review

Raymond James & Associates sold out of Charles & Colvard Ltd (CTHR) in Q1 2021, closing a stake of 2,161 shares — an estimated $27K sold.

Raymond James & Associates first reported a position in CTHR in Q3 2018 and held it in 9 quarters. The position peaked at $49K in Q4 2019. 39 funds tracked by Wall St. Rank hold CTHR as of Q1 2021.

  • Raymond James & Associates reported no remaining Charles & Colvard Ltd position as of Q1 2021 after selling out during the quarter.
  • Raymond James & Associates sold 2,161 Charles & Colvard Ltd shares in Q1 2021, an estimated $27K.
  • Raymond James & Associates first reported a position in Charles & Colvard Ltd in Q3 2018 and held it in 9 quarters.
  • Raymond James & Associates's Charles & Colvard Ltd position peaked at $49K in Q4 2019.
  • 39 funds tracked by Wall St. Rank held Charles & Colvard Ltd as of Q1 2021.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.